Blanket Purchase Agreement 36C25620A0043

Award Date 6/10/20
Last Date to Order 6/9/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Blanket Purchase Agreement to Accelerate Diagnostics, Inc. to procure a Rapid ID/AST system for the St. Louis VA Medical Center. The BPA has a potential value of $286,930 and period of performance through May 2, 2028. A $57,386 firm fixed price call was placed against the BPA for the Rapid ID/AST system. The Rapid ID/AST system will support the St. Louis VAMC in...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of automated microbiological blood culture testing equipment, reagents, and supplies. The BPA, with a total ceiling value of $2,295,562.32, was awarded to Biomerieux's Biomerieux, Inc. division, a foreign-owned, for-profit manufacturer of diagnostic solutions. The BPA, which does not have a set-aside designation, is intended to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded Biomerieux Inc. a blanket purchase agreement to provide microbiological identification and susceptibility testing equipment, reagents, and supplies. The single award BPA has a potential value of $469,809.55 and period of performance through September 30, 2021. Three firm fixed price call contracts were issued against the BPA with values of $110,913.31, $37,582.90, and $24,882.40...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 2 to Biofire Diagnostics LLC, a biotech company specializing in infectious disease diagnostic testing. The BPA, valued at $2,442,440.05, is a single-award contract established against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 (VISN 10) awarded a Blanket Purchase Agreement (BPA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $809,835 single-award BPA, which utilizes Biofire Diagnostics' General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests, will provide reagents to VA facilities in...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide microbiology reagents and consumables to support the VA's clinical testing programs nationwide. The contract has a ceiling value of $23,000,000 and a period of performance through October 19, 2027. This is a single-award contract without any set-aside designations. Under this BPA, the VA has issued several individual BPA...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the U.S. Department of Veterans Affairs (VA), to Biomerieux Inc., a global leader in in vitro diagnostics. The single-award BPA, valued at up to $14.4 million over its 5-year period of performance, allows the VA to procure Biomerieux's proprietary BioFire diagnostic platforms, reagents, and test kits to support infectious disease testing and pathogen detection at VA healthcare...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) awarded a single-award Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide Abbott ID NOW instruments and reagents. The $3,500,000 BPA, with a period of performance through September 2026, supports the VA's mission to provide veterans access to rapid point-of-care medical testing, particularly for respiratory illnesses like COVID-19 and...
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a blanket purchase agreement to Biomerieux Inc. for automated microbiological blood culture testing equipment, reagents, and supplies. The BPA establishes terms and conditions for subsequent fixed-price calls valued up to $331,475 to be placed through December 2022. Four calls have been awarded against the BPA to date for testing services and related products. These include a $1,485...
  • 36C25620A0043
    Blanket Purchase Agreement
  • 5
    Federal Contract Awards

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 16 awarded a Blanket Purchase Agreement (BPA) to Accelerate Diagnostics, Inc., a for-profit manufacturer, to provide instrumentation, reagents, and test kits needed to perform rapid identification and antimicrobial susceptibility testing (ID/AST) of positive blood cultures. This BPA, valued at up to $550,500, enables the VA to acquire these critical diagnostic products and services to support prompt diagnosis and treatment of bloodstream infections among veterans receiving care at VA medical facilities, particularly in Tucson, Arizona.

Through task orders issued under this BPA, the VA VHA VISN 16 has procured firm fixed price deliveries of the Accelerate Pheno system and associated consumables to equip clinical microbiology laboratories. These capabilities allow for faster identification of infectious pathogens and antimicrobial susceptibility testing compared to traditional methods, enabling earlier targeted therapy and reducing antimicrobial resistance. No small business or other socioeconomic set-asides were applied to this BPA or associated task orders, as the VA sought to leverage Accelerate Diagnostics' specialized expertise and product portfolio in support of veteran healthcare.

Generated 4/25/24, 6:28 PM